184 related articles for article (PubMed ID: 2498806)
1. The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription.
Schönthal A; Büscher M; Angel P; Rahmsdorf HJ; Ponta H; Hattori K; Chiu R; Karin M; Herrlich P
Oncogene; 1989 May; 4(5):629-36. PubMed ID: 2498806
[TBL] [Abstract][Full Text] [Related]
2. A direct role for c-fos in AP-1-dependent gene transcription.
Herrera R; Agarwal S; Walton K; Satterberg B; Distel RJ; Goodman R; Spiegelman BM; Roberts TM
Cell Growth Differ; 1990 Oct; 1(10):483-90. PubMed ID: 2126190
[TBL] [Abstract][Full Text] [Related]
3. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
Wasylyk B; Wasylyk C; Flores P; Begue A; Leprince D; Stehelin D
Nature; 1990 Jul; 346(6280):191-3. PubMed ID: 2114554
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of human c-fos expression by the retinoblastoma gene product.
Robbins PD; Horowitz JM; Mulligan RC
Nature; 1990 Aug; 346(6285):668-71. PubMed ID: 2117257
[TBL] [Abstract][Full Text] [Related]
5. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
6. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.
Sassone-Corsi P; Ransone LJ; Lamph WW; Verma IM
Nature; 1988 Dec; 336(6200):692-5. PubMed ID: 3143919
[TBL] [Abstract][Full Text] [Related]
7. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
Kutz SM; Providence KM; Higgins PJ
Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
[TBL] [Abstract][Full Text] [Related]
8. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
9. fos-jun Conspiracy: implications for the cell.
Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
[TBL] [Abstract][Full Text] [Related]
10. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
Angel P; Smeal T; Meek J; Karin M
New Biol; 1989 Oct; 1(1):35-43. PubMed ID: 2518690
[TBL] [Abstract][Full Text] [Related]
11. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.
Ryseck RP; Bravo R
Oncogene; 1991 Apr; 6(4):533-42. PubMed ID: 1827665
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun.
Touray M; Ryan F; Jaggi R; Martin F
Oncogene; 1991 Jul; 6(7):1227-34. PubMed ID: 1650443
[TBL] [Abstract][Full Text] [Related]
13. Autoregulation of fos: the dyad symmetry element as the major target of repression.
König H; Ponta H; Rahmsdorf U; Büscher M; Schönthal A; Rahmsdorf HJ; Herrlich P
EMBO J; 1989 Sep; 8(9):2559-66. PubMed ID: 2511006
[TBL] [Abstract][Full Text] [Related]
14. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
15. Regulation of IL-1-induced gingival collagenase gene expression by activator protein-1 (c-Fos/c-Jun).
Hamid QA; Reddy PJ; Tewari M; Uematsu S; Tuncay OC; Tewari DS
Cytokine; 2000 Nov; 12(11):1609-19. PubMed ID: 11052811
[TBL] [Abstract][Full Text] [Related]
16. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max.
Kirch HC; Flaswinkel S; Rumpf H; Brockmann D; Esche H
Oncogene; 1999 Apr; 18(17):2728-38. PubMed ID: 10348347
[TBL] [Abstract][Full Text] [Related]
17. fos and jun interaction: the role of the leucine zipper.
Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
19. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
Sellers JW; Struhl K
Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
[TBL] [Abstract][Full Text] [Related]
20. Novel phorbol ester response region in the collagenase promoter binds Fos and Jun.
Chamberlain SH; Hemmer RM; Brinckerhoff CE
J Cell Biochem; 1993 Jul; 52(3):337-51. PubMed ID: 8366145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
